A scientific booth to discuss about potential drug discovery seed/research will be available during the conference. Pre-registration is recommended, however we accept on-site registration, too, if spots available.


Date : July 26 (Thu.) - 27 (Fri.) 9：00～17：00
Venue: Exhibition Room (1F, No. 2 Building, Kobe International Exhibition Hall)

Takeda Pharmaceutical Company Limited  (website)

Takeda Pharmaceutical Company Limited is a patient-focused, innovation-driven global pharmaceutical company that builds on a distinguished 237-year history, aspiring to bring better health and a brighter future for people worldwide. We focus our research in neuroscience, oncology and gastroenterology (GI) disease areas. In April 2018, we opened the "Shonan Health Innovation Park: iPark" to promote open innovation in health care Japan area where neuroscience is one of the major areas of our research function in iPark. We center our focus in understanding neuropsychiatric disorders such as schizophrenia, autism, treatment resistant depression and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, ALS, Huntington's disease including immunological and inflammatory perspectives. Our outside-in mindset is focused on identifying innovations both outside and within our walls. We think differently – and creatively – about how we work with our partners and build on our combined strengths across all stages from research discovery to development. All researchers interested in scientific discussion for potential seed (non-confidential level) we kindly invite to visit our booth during the conference on July 26th-27th. Researchers from Neuroscience and Immunology unit will be present at the booth. Online pre-registration through the conference website is recommended, however we will also accept on-site registration.
Company website: https://www.takeda.com/.

If you wish to have an appointment with us, please copy the items below with your details and send by E-mail ( COCKPI-T@takeda.co.jp ).